vidarabine phosphate has been researched along with Carcinoma, Neuroendocrine in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alli, N; Balagopal, A; Bautista, M; Bhanumathy, KK; Dahiya, DK; Elhasasna, H; Freywald, A; Khan, R; Krishnan, A; Maranda, V; Patel, H; Vizeacoumar, FJ; Vizeacoumar, FS; Walke, P | 1 |
1 other study(ies) available for vidarabine phosphate and Carcinoma, Neuroendocrine
| Article | Year |
|---|---|
A Drug Repurposing Screen Identifies Fludarabine Phosphate as a Potential Therapeutic Agent for N-MYC Overexpressing Neuroendocrine Prostate Cancers.
Topics: Androgen Antagonists; Carcinoma, Neuroendocrine; Cell Line, Tumor; Drug Repositioning; Humans; Male; N-Myc Proto-Oncogene Protein; Prostatic Neoplasms; Reactive Oxygen Species; Vidarabine Phosphate | 2022 |